142 related articles for article (PubMed ID: 28599472)
1. Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.
Nakayama K; Rahman M; Rahman MT; Nakamura K; Sato E; Katagiri H; Ishibashi T; Ishikawa M; Iida K; Razia S; Ishikawa N; Kyo S
Oncol Lett; 2017 Jun; 13(6):4713-4719. PubMed ID: 28599472
[TBL] [Abstract][Full Text] [Related]
2. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
Zhang Y; Cheng Y; Ren X; Zhang L; Yap KL; Wu H; Patel R; Liu D; Qin ZH; Shih IM; Yang JM
Oncogene; 2012 Feb; 31(8):1055-64. PubMed ID: 21743489
[TBL] [Abstract][Full Text] [Related]
3. NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.
Jinawath N; Vasoontara C; Yap KL; Thiaville MM; Nakayama K; Wang TL; Shih IM
Oncogene; 2009 May; 28(18):1941-8. PubMed ID: 19305429
[TBL] [Abstract][Full Text] [Related]
4. Biological role and prognostic significance of NAC1 in ovarian cancer.
Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
[TBL] [Abstract][Full Text] [Related]
5. Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinoma.
Nishi T; Maruyama R; Urano T; Nakayama N; Kawabata Y; Yano S; Yoshida M; Nakayama K; Miyazaki K; Takenaga K; Tanaka T; Tajima Y
Pathol Int; 2012 Dec; 62(12):802-10. PubMed ID: 23252869
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.
Zhang Y; Cheng Y; Ren X; Hori T; Huber-Keener KJ; Zhang L; Yap KL; Liu D; Shantz L; Qin ZH; Zhang S; Wang J; Wang HG; Shih IeM; Yang JM
Cancer Res; 2012 Aug; 72(16):4262-75. PubMed ID: 22665267
[TBL] [Abstract][Full Text] [Related]
7. NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor.
Nakayama K; Nakayama N; Wang TL; Shih IeM
Cancer Res; 2007 Sep; 67(17):8058-64. PubMed ID: 17804717
[TBL] [Abstract][Full Text] [Related]
8. Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis.
Scofield MD; Korutla L; Jackson TG; Kalivas PW; Mackler SA
Neuroscience; 2012 Dec; 227():44-54. PubMed ID: 23022214
[TBL] [Abstract][Full Text] [Related]
9. The mouse nac1 gene, encoding a cocaine-regulated Bric-a-brac Tramtrac Broad complex/Pox virus and Zinc finger protein, is regulated by AP1.
Mackler SA; Homan YX; Korutla L; Conti AC; Blendy JA
Neuroscience; 2003; 121(2):355-61. PubMed ID: 14521994
[TBL] [Abstract][Full Text] [Related]
10. Multi-SUMOylation of NAC1 is essential for the growth of prostate cancer cells.
Wen D; Hu M; Guo W; Wu J; Wu Y
Biochem Biophys Res Commun; 2023 Jan; 641():148-154. PubMed ID: 36527749
[TBL] [Abstract][Full Text] [Related]
11. Cancer-related transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progression.
Nakayama N; Sakashita G; Nariai Y; Kato H; Sinmyozu K; Nakayama JI; Kyo S; Urano T; Nakayama K
Oncotarget; 2018 Jun; 9(47):28408-28420. PubMed ID: 29983869
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.
Liu P; Khurana A; Rattan R; He X; Kalloger S; Dowdy S; Gilks B; Shridhar V
Cancer Res; 2009 Jun; 69(11):4843-50. PubMed ID: 19487294
[TBL] [Abstract][Full Text] [Related]
13. NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.
Gao M; Herlinger AL; Wu R; Wang TL; Shih IM; Kong B; Rangel LBA; Yang JM
Aging (Albany NY); 2020 May; 12(10):9275-9291. PubMed ID: 32412910
[TBL] [Abstract][Full Text] [Related]
14. Nucleus Accumbens-Associated Protein 1 Expression Has Potential as a Marker for Distinguishing Oral Epithelial Dysplasia and Squamous Cell Carcinoma.
Sekine J; Nakatani E; Ohira K; Hideshima K; Kanno T; Nariai Y; Kagimura T; Urano T
PLoS One; 2015; 10(7):e0131752. PubMed ID: 26172271
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Du P; Zhang X; Liu H; Chen L
DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
[TBL] [Abstract][Full Text] [Related]
16. NAC1 modulates autoimmunity by suppressing regulatory T cell-mediated tolerance.
Yang JM; Ren Y; Kumar A; Xiong X; Das JK; Peng HY; Wang L; Ren X; Zhang Y; Ji C; Cheng Y; Zhang L; Alaniz RC; de Figueiredo P; Fang D; Zhou H; Liu X; Wang J; Song J
Sci Adv; 2022 Jul; 8(26):eabo0183. PubMed ID: 35767626
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights of NAC1 nuclear export and its role in ovarian cancer resistance to docetaxel.
Dong S; Wang X; Yang S; Guo F; Zhang J; Ji C; Shi L; Cheng Y; Hu Y; Li Z; Peng L; Guo L; Zhu W; Ren X; Yang JM; Zhang Y
Biochem Pharmacol; 2023 May; 211():115533. PubMed ID: 37019189
[TBL] [Abstract][Full Text] [Related]
18. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
19. Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion.
Ren Y; Kumar A; Das JK; Peng HY; Wang L; Balllard D; Xiong X; Ren X; Zhang Y; Yang JM; Song J
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150745
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
